Charles River Laboratories International Inc

CRL: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|Z@LOCK|&?%LOCK|xq>smhM

Charles River Earnings: Recovery Progress Continues Amid Strong Demand, but Expectations Look High

Charles River reported third-quarter revenue of $983 million, down 2% year over year due to divestitures, though organic revenue grew 4.7%. Management also raised its 2026 revenue outlook, now guiding to a 1.75% decline at the midpoint versus prior guidance of a 3.0% decline.

Sponsor Center